Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 1760-1764

  Ajdary, Soheila ^a   Alimohammadian, Mohammad H ^a   Eslami, Mohammad B ^a   Kemp, Kaare ^b   Kharazmi, Arsalan ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; LEISHMANIA MAJOR; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL DIVISION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; T-LYMPHOCYTES; TH1 CELLS;

EID: 0034029424     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.1760-1764.2000     Document Type: Article

References (31)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Bogdan, C., A. Gessner, W. Solbuch, and M. Rollinghoff. 1996. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8: 517-525.
3. Coutinho, S. G., M. P. Oliveira, A. M. Da-Cruz, P. M. De Luca, S. C. F. Mendonca, A. L. Berthol, L. Soong, and D. McMahon-Pratt. 1996. T cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania brasiliensis promastigote antigens: immunologic patterns associated with cure. Exp. Parasitol. 84:144-155.
4. Da-Cruz, A. M., F. Conceicao-Silva, A. L. Bertho, and S. G. Coutinho. 1994. Leishmania-reactive CD4 and CD8 T cells associated with cure of human cutaneous leishmaniasis. Infect. Immun. 62:2614-2618.
5. Fiorentino, D. F., A. Ziotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
6. Gaafar, A., A. Kharazmi, A. Ismail, M. Kemp, A. Hey, C. B. V. Christensen, M. Dafalla, A. Y. El Kadaro, A. M. El Hassan, and T. G. Theander. 1995. Dichotomy of T cell response to leishmania antigens in patients suffering from cutaneous leishmaniasis: absence or scarcity of Th1 activity is associated with severe infections. Clin. Exp. Immunol. 100:239-245.
7. Gasim, S., A. M. El Hassan, E. A. G. Khalil, A. Ismail, A. M. Y. Kadaro, A. Kharazmi, and T. G. Theander. 1998. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 111:64-69.
8. Ghalib, H. W., M. R. Puvezam, Y. M. Skeiky, M. Siddig, F. A. Hashim, A. M. El Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin-10 production correlates with pathology in human Leishmania donovani infection. J. Clin. Investig. 92:324-329.
9. Javadian, E., and A. Mesghali. 1974. Studies on cutaneous leishmaniasis in Khuzestan, Iran. 1. The leptomonad infection of sandflies. Bull. Soc. Pathol. Exot. Fil. 67:513-516.
10. Javadian, E., A. Nadim, G. Tahvildare-Bidrudi, and N. Assefi. 1976. Epidemiology of cutaneous leishmaniasis in Iran B. Khorassan, V. Report on a focus of zoonotic cutaneous leishmaniasis in Esferayen. Bull. Soc. Pathol. Exot. Fil. 69:140-143.
11. Kemp, K., L. Hviid, A. Kharazmi, and M. Kemp. 1997. IFN-γ production by human T cells and natural killer cells in vitro in response to antigens from two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand. J. Immunol. 46:495-499.
12. Kemp, K., T. G. Theander, L. Hviid, A. Gafaar, A. Kharazmi, and M. Kemp. 1999. IFN-γ and TNF-α producing cells in humans who are immune to cutaneous leishmaniasis. Scand. J. Immunol. 49:655-659.
13. Kemp, M., A. S. Hey, J. A. L. Kurtzhals, C. B. V. Christensen, A. Gaafar, M. D. Mustafa, A. A. Y. Kordofani, A. Ismail, A. Kharazmi, and T. G. Theander. 1994. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin. Exp. Immunol. 96: 410-415.
14. Kemp, M., E. Handman, K. Kemp, A. Ismail, M. D. Mustafa, A. Y. Kordofani, K. Bendtzen, A. Kharazmi, and T. G. Theander. 1998. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognized by Th1 cells in humans with naturally acquired immunity to L. major. FEMS Immunol. Med. Microbiol. 20:209-218.
15. Kemp, M., T. G. Theander, and A. Kharazmi. 1996. The contrasting roles of CD4+ T cells in intracellular infections in human: Leishmania as an example. Immunol. Today 17:13-16.
16. Kurtzhals, J. A. L., A. S. Hey, A. Jardim, M. Kemp, K. U. Schaefer, E. O. Odera, C. B. V. Christensen, G. I. Githure, R. W. Olafson, T. G. Theander, and A. Kharazmi. 1994. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan associated protein in cells from cured visceral leishmaniasis patients. Clin. Exp. Immunol. 96:416-421.
17. Louis, J., H. Himmelrich, C. Parra-Lopez, F. Tacchini-Cottier, and P. Launois. 1998. Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10:459-464.
18. Louzir, H., P. C. Melby, A. Ben Salah, H. Marrakchi, K. Aoun, R. Ben Ismail, and K. Dellagi. 1998. Immunologic determinants of disease evaluation in localized cutaneous leishmaniasis due to Leishmania major. J. Infect. Dis. 177:1687-1695.
19. Maasho, K., F. Sanchez, E. Schurr, A. Hailu, and H. Akuffo. 1998. Indications of the protective role of natural killer cells in human cutaneous leishmaniasis of endemicity. Infect. Immun. 66:2698-2704.
20. Melby, P. C., F. Andrade-Narraez, B. J. Darnell, and G. Valencia-Pacheco. 1996. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis. FEMS Immunol. Med. Microbiol. 15:101-107.
21. Moore, K. W., A. O'Garra, M. R. de-Waal, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
22. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in cross regulation of Th1 and Th2 responses. Immunol. Today 12:49-53.
23. Nilsen, R., and R. N. Mshana. 1987. In situ characterization of the cellular immune response in Ethiopian cutaneous leishmaniasis. Scand. J. Immunol. 26:503-512.
24. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. Conceicao-Silva, and R. Modlin. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Investig. 91:1390-1395.
25. Rafati, S., S. Couty-jouve, M. H. Alimohammadian, and J. A. Louis. 1997. Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis. Clin. Exp. Immunol. 110:203-211.
26. Reiner, S. L., and R. Locksly. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
27. Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147: 3149-3155.
28. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in murine model I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139:221-227.
29. Swihart, K., U. Fruth, N. Messmer, K. Hug, R. Behin, S. Huang, G. Del-Giudice, M. Aguet, and J. A. Leuis. 1995. Mice from genetically resistant background lacking IFN-g receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell type-1 CD4 T cell response. J. Exp. Med. 181:961-971.
30. World Health Organization. 1996. Information circulation. WHO Mediterranian Zoonosis Control Center. 40:11-13.
31. Yaghoobi-Ershadi, M. R., and E. Javadian. 1996. Epidemiological study of reservoir hosts in an endemic area of zoonotic cutaneous leishmaniasis. Bull. W. H. O. 74:587-590.